Activation of transforming growth factor-β1 and early atherosclerosis in systemic lupus erythematosus

被引:32
|
作者
Jackson, Michelle
Ahmad, Yasmeen
Bruce, Ian N.
Coupes, Beatrice
Brenchley, Paul E. C.
机构
[1] Manchester Royal Infirm, Manchester Inst Nephrol & Transplantat, Renal Res Labs, Manchester M13 9WL, Lancs, England
[2] Univ Manchester, Manchester Royal Infirm, Cent Manchester & Manchester Childrens Univ NHS T, Rheumatism Res Ctr, Manchester M13 9WL, Lancs, England
基金
英国惠康基金;
关键词
D O I
10.1186/ar1951
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The efficiency of activating latent transforming growth factor (TGF)-beta(1) in systemic lupus erythematosus (SLE) may control the balance between inflammation and fibrosis, modulating the disease phenotype. To test this hypothesis we studied the ability to activate TGF-beta(1) in SLE patients and control individuals within the context of inflammatory disease activity, cumulative organ damage and early atherosclerosis. An Activation Index ( AI) for TGF-beta(1) was determined for 32 patients with SLE and 33 age-matched and sex-matched control individuals by quantifying the increase in active TGF-beta(1) under controlled standard conditions. Apoptosis in peripheral blood mononuclear cells was determined by fluorescence-activated cell sorting. Carotid artery intima-media thickness was measured using standard Doppler ultrasound. These measures were compared between patients and control individuals. In an analysis conducted in patients, we assessed the associations of these measures with SLE phenotype, including early atherosclerosis. Both intima-media thickness and TGF-beta(1) AI for SLE patients were within the normal range. There was a significant inverse association between TGF-beta(1) AI and levels of apoptosis in peripheral blood mononuclear cells after 24 hours in culture for both SLE patients and control individuals. Only in SLE patients was there a significant negative correlation between TGF-beta(1) AI and low-density lipoprotein cholesterol ( r = - 0.404; P = 0.022) and between TGF-beta(1) AI and carotid artery intima-media thickness ( r = - 0.587; P = 0.0004). A low AI was associated with irreversible damage (SLICC [ Systemic Lupus International Collaborating Clinics] Damage Index = 1) and was inversely correlated with disease duration. Intima-media thickness was significantly linked to total cholesterol ( r = 0.371; P = 0.037). To conclude, in SLE low normal TGF-beta(1) activation was linked with increased lymphocyte apoptosis, irreversible organ damage, disease duration, calculated low-density lipoprotein levels and increased carotid IMT, and may contribute to the development of early atherosclerosis.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Transforming growth factor-β signaling in systemic sclerosis
    Nolan B.Ayers
    Chenming Sun
    Shi-You Chen
    The Journal of Biomedical Research, 2018, 32 (01) : 3 - 12
  • [32] Activation of transforming growth factor-β1 in diabetic kidney disease
    Hellmich, B
    Schellner, M
    Schatz, H
    Pfeiffer, A
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2000, 49 (03): : 353 - 359
  • [33] Heparin Inhibits Activation of Latent Transforming Growth Factor-β1
    Lee, Mee Jeong
    PHARMACOLOGY, 2013, 92 (5-6) : 238 - 244
  • [34] Altered regulatory T Cells (Treg cells) and transforming growth factorβ1 (TGFβ1) activation in pregnant women with systemic lupus erythematosus (SLE)
    Tower, C.
    Varghese, S.
    Chirico, D.
    Crocker, I.
    Bruce, I.
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2012, 94 (01) : 50 - 51
  • [35] Microarray study reveals a transforming growth factor-β-dependent mechanism of fibrosis in discoid lupus erythematosus
    Sole, C.
    Gimenez-Barcons, M.
    Ferrer, B.
    Ordi-Ros, J.
    Cortes-Hernandez, J.
    BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 (02) : 302 - 313
  • [36] The role of proteases in transforming growth factor-β activation
    Jenkins, Gisli
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2008, 40 (6-7): : 1068 - 1078
  • [37] Transforming growth factor-β1 polymorphisms in Korean patients with systemic sclerosis
    Lee, EB
    Kim, JY
    Lee, YJ
    Abdallah, A
    Lympany, P
    Song, YW
    TISSUE ANTIGENS, 2004, 63 (05): : 491 - 495
  • [38] The multi-faceted role of transforming growth factor-beta in systemic lupus erythematosus
    Youinou, P
    Le Corre, R
    LUPUS, 1999, 8 (02) : 87 - 88
  • [39] Macrophage Activation and Coronary Atherosclerosis in Systemic Lupus Erythematosus and Rheumatoid Arthritis
    Rho, Young Hee
    Solus, Joseph
    Raggi, Paolo
    Oeser, Annette
    Gebretsadik, Tebeb
    Shintani, Ayumi
    Stein, C. Michael
    ARTHRITIS CARE & RESEARCH, 2011, 63 (04) : 535 - 541
  • [40] Fucoidan inhibits activation and receptor binding of transforming growth factor-β1
    Kim, Tae Hee
    Lee, Eun Kyoung
    Lee, Mee Jeong
    Kim, Ji Hyun
    Yang, Won Seok
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 432 (01) : 163 - 168